Cargando…
Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
The therapeutic efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is limited by the development of graft-versus-host disease (GVHD). In GVHD, rigorous pre-conditioning regimen resets the immune landscape and inflammatory milieu causing immune dysregulation, characterized by...
Autores principales: | Mohamed, Fathima A., Thangavelu, Govindarajan, Rhee, Stephanie Y., Sage, Peter T., O’Connor, Roddy S., Rathmell, Jeffrey C., Blazar, Bruce R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546182/ https://www.ncbi.nlm.nih.gov/pubmed/34712243 http://dx.doi.org/10.3389/fimmu.2021.757836 |
Ejemplares similares
-
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2019) -
Targeting the Retinoid X Receptor Pathway Prevents and Ameliorates Murine Chronic Graft-Versus-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2022) -
Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease
por: Hippen, Keli L., et al.
Publicado: (2022) -
Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
por: Le, Hongnga T., et al.
Publicado: (2020) -
Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)